Veterinary Medicines Information website

MORAXEBIN Neo

Authorised
  • Moraxella bovis, strain CAMP 6334 (Kalnice), Inactivated
  • Moraxella bovis, strain CAMP 6335 (Polerady), Inactivated
  • Moraxella bovis, strain CAMP 6336 (Karlov), Inactivated

Product identification

Medicine name:
MORAXEBIN Neo
Active substance:
  • Moraxella bovis, strain CAMP 6334 (Kalnice), Inactivated
  • Moraxella bovis, strain CAMP 6335 (Polerady), Inactivated
  • Moraxella bovis, strain CAMP 6336 (Karlov), Inactivated
Target species:
  • Cattle
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Moraxella bovis, strain CAMP 6334 (Kalnice), Inactivated
    8.00
    log10 colony forming unit(s)
    /
    2.00
    millilitre(s)
  • Moraxella bovis, strain CAMP 6335 (Polerady), Inactivated
    8.00
    log10 colony forming unit(s)
    /
    2.00
    millilitre(s)
  • Moraxella bovis, strain CAMP 6336 (Karlov), Inactivated
    8.00
    log10 colony forming unit(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AC
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 160049
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 15/12/2021